These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 28110841

  • 1. Treatment of autoimmune thrombotic thrombocytopenic purpura in the more severe forms.
    Coppo P, French Reference Center for Thrombotic Microangiopathies.
    Transfus Apher Sci; 2017 Feb; 56(1):52-56. PubMed ID: 28110841
    [Abstract] [Full Text] [Related]

  • 2. Management of thrombotic thrombocytopenic purpura.
    Coppo P, French Reference Center for Thrombotic Microangiopathies.
    Transfus Clin Biol; 2017 Sep; 24(3):148-153. PubMed ID: 28645643
    [Abstract] [Full Text] [Related]

  • 3. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
    Coppo P, Froissart A, French Reference Center for Thrombotic Microangiopathies.
    Hematology Am Soc Hematol Educ Program; 2015 Sep; 2015():637-43. PubMed ID: 26637782
    [Abstract] [Full Text] [Related]

  • 4. Thrombotic thrombocytopenic purpura.
    Joly BS, Coppo P, Veyradier A.
    Blood; 2017 May 25; 129(21):2836-2846. PubMed ID: 28416507
    [Abstract] [Full Text] [Related]

  • 5. Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura.
    Dane K, Chaturvedi S.
    Hematology Am Soc Hematol Educ Program; 2018 Nov 30; 2018(1):539-547. PubMed ID: 30504355
    [Abstract] [Full Text] [Related]

  • 6. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
    Coppo P, Veyradier A.
    Presse Med; 2012 Mar 30; 41(3 Pt 2):e163-76. PubMed ID: 22265954
    [Abstract] [Full Text] [Related]

  • 7. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M, Benhamou Y, Delmas Y, Pichereau C, Maury E, Pène F, Halimi JM, Presne C, Thouret JM, Veyradier A, Coppo P.
    Eur J Haematol; 2016 Aug 30; 97(2):183-91. PubMed ID: 26608617
    [Abstract] [Full Text] [Related]

  • 8. Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents.
    Gómez-De León A, Villela-Martínez LM, Yáñez-Reyes JM, Gómez-Almaguer D.
    Expert Rev Hematol; 2020 May 30; 13(5):461-470. PubMed ID: 32243196
    [Abstract] [Full Text] [Related]

  • 9. Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.
    Patriquin CJ, Thomas MR, Dutt T, McGuckin S, Blombery PA, Cranfield T, Westwood JP, Scully M.
    Br J Haematol; 2016 Jun 30; 173(5):779-85. PubMed ID: 27009919
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of thrombotic thrombocytopenic purpura].
    Galstyan GM, Maschan AA, Klebanova EE, Kalinina II.
    Ter Arkh; 2021 Jun 15; 93(6):736-745. PubMed ID: 36286842
    [Abstract] [Full Text] [Related]

  • 11. Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
    Kubo M, Matsumoto M.
    Int J Hematol; 2023 Mar 15; 117(3):331-340. PubMed ID: 36757521
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab.
    Sankararaman S, Jeroudi M, Ibrahim H.
    Pediatr Int; 2014 Dec 15; 56(6):914-918. PubMed ID: 25521977
    [Abstract] [Full Text] [Related]

  • 13. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
    Pandey S, Nakagawa M, Rosenbaum ER, Arnaoutakis K, Hutchins LF, Makhoul I, Milojkovic N, Cottler-Fox M.
    J Clin Apher; 2015 Feb 15; 30(1):50-4. PubMed ID: 25042026
    [Abstract] [Full Text] [Related]

  • 14. Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report.
    Saleem R, Rogers ZR, Neunert C, George JN.
    Transfusion; 2019 Mar 15; 59(3):921-926. PubMed ID: 30548440
    [Abstract] [Full Text] [Related]

  • 15. [Diagnosis and treatment of thrombotic thrombocytopenic purpura].
    Kubo M, Matsumoto M.
    Rinsho Ketsueki; 2020 Mar 15; 61(5):529-535. PubMed ID: 32507820
    [Abstract] [Full Text] [Related]

  • 16. Rituximab in autoimmune thrombotic thrombocytopenic purpura: A success story.
    Froissart A, Veyradier A, Hié M, Benhamou Y, Coppo P, French Reference Center for Thrombotic Microangiopathies.
    Eur J Intern Med; 2015 Nov 15; 26(9):659-65. PubMed ID: 26293834
    [Abstract] [Full Text] [Related]

  • 17. [Refractory thrombotic thrombocytopenic purpura achieving complete remission with rituximab treatment].
    Iino H, Ogawa Y, Yanagisawa K, Shimizu H, Mitsui T, Ishizaki T, Hayakawa M, Matsumoto M, Nojima Y, Handa H.
    Rinsho Ketsueki; 2017 Nov 15; 58(3):204-209. PubMed ID: 28381686
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of immune-mediated thrombotic thrombocytopenic purpura: A decisive turning point].
    Poullin P.
    Transfus Clin Biol; 2021 Nov 15; 28(4):380-385. PubMed ID: 34464709
    [Abstract] [Full Text] [Related]

  • 19. Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI).
    Cid J, Pérez-Valencia AI, Torrente MÁ, Ávarez-Larrán A, Díaz-Ricart M, Esteve J, Lozano M.
    Transfus Apher Sci; 2021 Feb 15; 60(1):103011. PubMed ID: 33221124
    [Abstract] [Full Text] [Related]

  • 20. A 14-Year Experience in the Management of Patients with Acquired Immune Thrombotic Thrombocytopenic Purpura in Northern Israel.
    Rinott N, Mashiach T, Horowitz NA, Schliamser L, Sarig G, Keren-Politansky A, Dann EJ.
    Acta Haematol; 2015 Feb 15; 134(3):170-6. PubMed ID: 25997685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.